AML 0.00% 0.6¢ aeon metals limited.

macca's view - it'll be a long wait

  1. Yak
    13,672 Posts.
    Note how much WAS NOT disclosed

    AMRAD Recommendation change
    AMRAD has struck a licensing deal with the Australian subsidiary of US pharmaceutical company Merck Sharp & Dohme. AMRAD has received an upfront payment of US$5m with the potential for further milestone payments and future royalties.
    The actual technology at the centre of the deal was not disclosed. It stems from research conducted by AMRAD and partners, that is based on a "target" for which drugs are developed to act upon. At this stage, the most advanced therapeutic area is for the treatment of asthma and the deal would ideally lead to the development of drugs for this indication.
    Additional areas that may deliver drug candidates include other respiratory diseases and oncology (anti-cancer compounds). AMRAD has valued the best outcome from the deal at US$112m plus royalties. However, to achieve this, the technology would need to deliver a human health product for all indications (i.e. not just asthma).
    Actual indications were not disclosed nor was the timeframe.

    It would be fair to say that the commercialisation of a product would take up to ten years. Hence the reality is, it will be a long road to achieve the full potential of this deal but there will be shorter-term milestone payments available.

    We have upgraded our short term recommendation to Hold. Although the size and timing of future payments from this deal are unclear, the upfront US$5m is a positive sign for AMRAD’s technology. We highlight that the stock remains speculative due to the early stage pipeline and uncertainty of future cashflows.
 
watchlist Created with Sketch. Add AML (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $6.578M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $3.492K 582K

Buyers (Bids)

No. Vol. Price($)
29 6346119 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 505002 3
View Market Depth
Last trade - 14.18pm 29/03/2024 (20 minute delay) ?
AML (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.